Abstract:Abstract One of the major public health problems globally, malaria, is mainly caused protozoan parasites from the genus Plasmodium, and commonly spreads to people through the bites of infected female mosquitoes of the genus Anopheles. Strategies for treatment, prevention, and control are available for malaria but the eradication of malaria still poses great challenge due to plasmodium’s drug resistance over the past decades. Development of novel antimalarial drugs remains a significant task to protect people from malaria. N-Myristoyl transferase is responsible for the N-Myristoylation catalysis process and the survival of Plasmodium species. Thus, it is considered a therapeutic drug target in protozoans and was recently validated as a significant target for Plasmodium vivax. In this present scenario, we endeavour to identify effective NMT inhibitors to prevent the onset of malaria in the human species. Initially, the structure-based virtual screening was executed against ZINC database and four potential candidates for NMT were identified. Furthermore, the four identified compounds were subjected to ADME prediction and all the four compounds found within adequate range with predicted ADME properties. Eventually, we conducted the molecular dynamics simulation to investigate the binding stability of top three protein-ligand complexes at different time scale by employing the tool Desmond. The molecular dynamics simulation studies revealed the protein-ligand complexes were stable throughout the entire simulation. Besides, we noticed that the residues ASN 365, PHE 103 and HIS 213 of NMT were crucially involved in the formation of various intermolecular interactions, significantly contributing to the stability of protein-ligand complexes. From this computational investigation, we suggest that the three identified potential compounds are extremely useful for further lead optimization and drug development.

Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development

An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs

Transmission-Blocking Strategies Against Malaria Parasites During Their Mosquito Stages

Structure-Based Virtual Screening, Insilico Docking, ADME Prediction, and Molecular Dynamics Studies for Identification of Potential NMT Inhibitors Against Malaria

A Class of Tricyclic Compounds Blocking Malaria Parasite Oocyst Development and Transmission

Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box

Towards next-generation treatment options to combat Plasmodium falciparum malaria

Host-targeted Interventions as an Exciting Opportunity to Combat Malaria

New dimensions in the field of antimalarial research against malaria resurgence

A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation.

Antimalarial drug discovery: progress and approaches

Eliminating malaria transmission requires targeting immature and mature gametocytes through lipoidal uptake of antimalarials

Breaking Boundaries in Malaria Research: Design of a Genetic Tool for High-Throughput Gametocidal Drug Screening

Drug-Resistant Falciparum Malaria: Mechanisms, Consequences, and Challenges

The past, present and future of anti-malarial medicines

Investigation of Drug-Resistant Mechanism of Malaria Parasites by Transfection Technology

Malaria Biology and Disease Pathogenesis: Insights for New Treatments

Bioactive compounds as therapeutic proposals against Plasmodium falciparum : A systematic review

Repositioning Brusatol as a Transmission Blocker of Malaria Parasites

The Biological Control of the Malaria Vector

Recent Advances in the Treatment of Malaria